Press "Enter" to skip to content

Medicare patients have low adherence to biologic drug therapy for psoriasis

About half of Medicare patients who start taking biologic therapies for moderate to severe plaque psoriasis stop within a year, according to a new study led by researchers from the Perelman School…

Source: MedicalNewsToday.com